Expanding screening via next-generation sequencing (NGS) to include other established (e.g., MYO15A, OTOF, CDH23, TMC1) and emerging deafness genes would significantly enhance diagnostic yield and capture a broader spectrum of genetic causes. The gene discussed is MYO15A; the disease is deafness.